Moderna stock climbs 8% amid head/neck cancer vaccine data
Moderna stock climbs 8% amid head/neck cancer vaccine data
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
What made Moderna stock pop 10% on Tuesday?
Moderna Inc (NASDAQ: MRNA) popped as much as 10% on Tuesday after a Jefferies analyst made upbeat remarks on new data for its..
Invezz